| Quote
: |
黄羚,江媚,马丽然,康佳.基于数据挖掘和网络药理学的《临证指南医案·癥瘕》用药研究[J].湖南中医药大学学报英文版,2020,40(7):860-866.[Click to copy
] |
|
| |
|
|
| This paper
：Browser 1783times Download 471times |
| 基于数据挖掘和网络药理学的《临证指南医案·癥瘕》用药研究 |
| 黄羚,江媚,马丽然,康佳 |
| (北京中医药大学, 北京 100029;北京市鼓楼中医医院, 北京 100009) |
| 摘要: |
| 目的 挖掘《临证指南医案·癥瘕》的组方用药规律，探索治疗癥瘕基本组方的主要活性成分，初步研究治疗癥瘕基本组方的治疗机制。方法 收集《临证指南医案·癥瘕》的病案，采用TCMISS软件进行组方数据分析，探讨用药规律，挖掘核心药物及新处方，运用TCMSP、TCM-Mesh、HIT、TCM-ID、HPO、DrugBank、CTDg及KEGG数据库分析治疗癥瘕基本组方各药物靶标间相互作用关系及相关通路。运用STRING探讨其相关性。结果 得到组方32则，药物75种，挖掘出2个核心药物组合和治疗癥瘕基本组方，得到治疗癥瘕基本组方的靶标基因1 397个，癥瘕的靶标基因46个，药物-疾病交集靶标基因15个，相关通路75条，其中女性腹部赘生物相关通路8条。结论 叶天士治疗癥瘕以痰瘀同治、理气化痰、活血化瘀为主，其机制可能为机体激素应答和免疫应答等，同时受"下丘脑-垂体-卵巢生殖轴"相关通路和女性腹部赘生物相关通路等多靶标复杂通路的共同影响。 |
| 关键词: 临证指南医案 癥瘕 数据挖掘 网络药理学 理气化痰 活血化瘀 叶天士 |
| DOI：10.3969/j.issn.1674-070X.2020.07.015 |
| Received:July 22, 2019 |
| 基金项目:国家自然科学基金项目（81904240）；北京中医药薪火传承“3+3”工程基层老中医传承工作室建设项目——东城区康佳知名中医工作室。 |
|
| Study on Medication in Abdominal Mass, Guide to Clinical Practice with Medical Records Based on Data Mining and Network Pharmacology |
| HUANG Ling,JIANG Mei,MA Liran,KANG Jia |
| (Beijing University of Chinese Medicine, Beijing 100029, China;Gulou Hospital of Traditional Chinese Medicine, Beijing 100009, China) |
| Abstract: |
| Objective To excavate medication rules of prescriptions in Abdominal Mass, Guide to Clinical Practice with Medical Records, to explore active ingredients of the basic prescription in the treatment of abdominal mass, and to initially analyze the treatment mechanism of the basic prescription for abdominal mass. Methods Medica cases in Abdominal Mass, Guide to Clinical Practice with Medical Records were collecteds. TCMISS was used to analyze data of prescriptions, to explore the medication rules, core drugs and new prescriptions. TCMSP, TCM-Mesh, HIT, TCM-ID, HPO, DrugBank,CTDg and KEGG were used to analyze interaction between herb-disease targets and the related pathways in the treatment of abdominal mass. The correlation was analyzed by STRING. Results Totally 32 prescriptions were included, containing 75 herbs. 2 core drug-pairs and basic prescriptions for abdominal mass treatment were evacuated. 1397 targets genes of basic prescriptions for abdominal mass treatment and 46 targets genes for abdominal mass, 15 drug-disease intersection targets genes, 75 related pathways were obtained. Among them, 8 pathways were mainly related to female abdominal neoplasm. Conclusion The general rules of YE Tianshi in treating abdominal mass are treating both phlegm and stasis, regulating Qi and resolving phlegm, promoting blood circulation and removing blood stasis. Its mechanism might be the hormone response and immune response. It was affected by complex multi-targets and multi-pathways related with "hypothalamus-pituitary-ovary reproductive axis" and female abdominal neoplasm's pathways. |
| Key words: Guide to Clinical Practice with Medical Records abdominal mass data mining network pharmacology regulating Qi and resolving phlegm promoting blood circulation and removing blood stasis YE Tianshi |
|
二维码（扫一下试试看！） |
|
|
|
|
